The aim of this thesis was to develop and characterize flow-through reactors based on the immobilization of alternative aspartic proteases-mucorpepsin and rhizopuspepsin-and to evaluate their applicability for the digestion of model proteins and the therapeutic monoclonal antibody Trastuzumab…

Source: https://dspace.cuni.cz/handle/20.500.11956/198905